Severe pulmonary hypertension and chronic obstructive pulmonary disease

被引:451
作者
Chaouat, A [1 ]
Bugnet, AS [1 ]
Kadaoui, N [1 ]
Schott, R [1 ]
Enache, I [1 ]
Ducoloné, A [1 ]
Ehrhart, M [1 ]
Kessler, R [1 ]
Weitzenblum, E [1 ]
机构
[1] Hop Hautepierre, Serv Pneumol, F-67098 Strasbourg, France
关键词
chronic obstructive pulmonary disease; pulmonary artery pressure; pulmonary hypertension; respiratory function tests;
D O I
10.1164/rccm.200401-006OC
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Rationale: Severe pulmonary hypertension occurs occasionally in patients with chronic obstructive pulmonary disease (COPD), but no detailed description of these patients is available. Objectives: To identify and characterize patients with COPD and severe pulmonary hypertension. Methods: Retrospective study of 27 patients with COPD with severe pulmonary hypertension (pulmonary artery mean pressure [Ppa], >= 40 mm Hg) among 998 patients who underwent right heart catheterization between 1990 and 2002 as part of a workup for chronic respiratory failure during a period of disease stability. Results: Of the 27 patients, 16 had another disease capable of causing pulmonary hypertension. The remaining I I (I I of 998, 1.1%) patients had COPD as the only cause of pulmonary hypertension, with a median Ppa of 48 mm Hg (interquartile range, 46-50). They had an unusual pattern of cardiopulmonary abnormalities with mild to moderate airway obstruction, severe hypoxemia, hypocapnia, and a very low diffusing capacity for carbon monoxide (p < 0.01 compared with a control group of patients with COPD). Exertional dyspnea was more severe (p < 0.01) and survival was shorter (p = 0.0026) than in the control subjects. Conclusions: Severe pulmonary hypertension is uncommon in patients with COPD. When it occurs, another cause must be sought. COPD with severe pulmonary hypertension and no other possible cause shares features with pulmonary vascular diseases, such as idiopathic pulmonary hypertension.
引用
收藏
页码:189 / 194
页数:6
相关论文
共 30 条
[1]   Appetite-suppressant drugs and the risk of primary pulmonary hypertension [J].
Abenhaim, L ;
Moride, Y ;
Brenot, F ;
Rich, S ;
Benichou, J ;
Kurz, X ;
Higenbottam, T ;
Oakley, C ;
Wouters, E ;
Aubier, M ;
Simonneau, G ;
Begaud, B .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (09) :609-616
[2]  
[Anonymous], 1963, CIRCULATION, V27, P594
[3]  
[Anonymous], EUROPEAN RESP J
[4]   CARDIOVASCULAR COMPLICATIONS OF CHRONIC-BRONCHITIS AND EMPHYSEMA [J].
BISHOP, JM .
MEDICAL CLINICS OF NORTH AMERICA, 1973, 57 (03) :771-780
[5]   PATTERNS OF CARDIOVASCULAR DYSFUNCTION IN CHRONIC OBSTRUCTIVE LUNG-DISEASE [J].
BURROWS, B ;
RABINOWITZ, M ;
KETTEL, LJ ;
DIENER, CF ;
NIDEN, AH .
NEW ENGLAND JOURNAL OF MEDICINE, 1972, 286 (17) :912-+
[6]  
BURROWS B, 1974, AM REV RESPIR DIS, V110, P64
[7]  
Chaouat A, 2003, AM J RESP CRIT CARE, V167, pA696
[8]   Polymorphism of the serotonin transporter gene and pulmonary hypertension in chronic obstructive pulmonary disease [J].
Eddahibi, S ;
Chaouat, A ;
Morrell, N ;
Fadel, E ;
Fuhrman, C ;
Bugnet, AS ;
Dartevelle, P ;
Housset, B ;
Hamon, M ;
Weitzenblum, E ;
Adnot, S .
CIRCULATION, 2003, 108 (15) :1839-1844
[9]  
Fishman A, 2003, NEW ENGL J MED, V348, P2059
[10]  
FISHMAN AP, 1976, AM REV RESPIR DIS, V114, P775